The DOI matches its Crossref record; 197 of the 197 references it cites were found in a registry or an index.
G protein-coupled receptors: novel targets for drug discovery in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Vivacqua, A., Bonofiglio, D., Albanito, L., Madeo, A., Rago, V., Carpino, A., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026344 · Cited by 280
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., & Moore, P. S. (1994) · Science · doi:10.1126/science.7997879 · Cited by 5,654
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Cancer and the chemokine network
Balkwill, F. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1388 · Cited by 2,343
Mammalian Rho GTPases: new insights into their functions from in vivo studies
Heasman, S. J., & Ridley, A. J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2476 · Cited by 1,871
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Stromal gene expression predicts clinical outcome in breast cancer
Finak, G., Bertos, N., Pepin, F., Sadekova, S., Souleimanova, M., Zhao, H., Chen, H., Omeroglu, G., Meterissian, S., Omeroglu, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1764 · Cited by 1,687
Binding of GSK3β to the APC-β-Catenin Complex and Regulation of Complex Assembly
Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., & Polakis, P. (1996) · Science · doi:10.1126/science.272.5264.1023 · Cited by 1,422
G-protein-coupled receptors and cancer
Dorsam, R. T., & Gutkind, J. S. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2069 · Cited by 1,388
Filardo, E. J. (2000) · Molecular Endocrinology · doi:10.1210/me.14.10.1649 · Cited by 1,383
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer
Kumar, V., & Chambon, P. (1988) · Cell · doi:10.1016/0092-8674(88)90017-7 · Cited by 1,220
Hedgehog: functions and mechanisms
Varjosalo, M., & Taipale, J. (2008) · Genes & Development · doi:10.1101/gad.1693608 · Cited by 1,217
The emerging role of lysophosphatidic acid in cancer
Mills, G. B., & Moolenaar, W. H. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1143 · Cited by 1,094
ADAMs: key components in EGFR signalling and development
Blobel, C. P. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1548 · Cited by 1,090
Hedgehog Signaling in Development and Cancer
Jiang, J., & Hui, C.-C. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.11.010 · Cited by 1,063
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
G-protein-coupled receptors and signaling networks: emerging paradigms
Marinissen, M. J., & Gutkind, J. S. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01678-3 · Cited by 1,049
LDL receptor-related proteins 5 and 6 in Wnt/β-catenin signaling:Arrows point the way
He, X., Semenov, M., Tamai, K., & Zeng, X. (2004) · Development · doi:10.1242/dev.01117 · Cited by 1,044
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
Rudin, C. M., Hann, C. L., Laterra, J., Yauch, R. L., Callahan, C. A., Fu, L., Holcomb, T., Stinson, J., Gould, S. E., Coleman, B., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0902903 · Cited by 1,019
Wang, C.-Y., Cusack, J. C., Liu, R., & Baldwin, A. S. (1999) · Nature Medicine · doi:10.1038/7410 · Cited by 988
Dowling, R. J. O., Zakikhani, M., Fantus, I. G., Pollak, M., & Sonenberg, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2310 · Cited by 933
Buzzai, M., Jones, R. G., Amaravadi, R. K., Lum, J. J., DeBerardinis, R. J., Zhao, F., Viollet, B., & Thompson, C. B. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4447 · Cited by 923
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature · doi:10.1038/nature01874 · Cited by 870
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
The tumour microenvironment as a target for chemoprevention
Albini, A., & Sporn, M. B. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2067 · Cited by 823
Virtual and biomolecular screening converge on a selective agonist for GPR30
Bologa, C. G., Revankar, C. M., Young, S. M., Edwards, B. S., Arterburn, J. B., Kiselyov, A. S., Parker, M. A., Tkachenko, S. E., Savchuck, N. P., Sklar, L. A., et al. (2006) · Nature Chemical Biology · doi:10.1038/nchembio775 · Cited by 818
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
Rho GTPases in cancer cell biology
Vega, F. M., & Ridley, A. J. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.04.039 · Cited by 779
The significance of cancer cell expression of the chemokine receptor CXCR4
Balkwill, F. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2003.10.003 · Cited by 758
Mining the Wnt pathway for cancer therapeutics
Barker, N., & Clevers, H. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2154 · Cited by 743
Serine Phosphorylation-regulated Ubiquitination and Degradation of β-Catenin
Orford, K., Crockett, C., Jensen, J. P., Weissman, A. M., & Byers, S. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.24735 · Cited by 714
Insights into G Protein Structure, Function, and Regulation
Cabrera-Vera, T. M., Vanhauwe, J., Thomas, T. O., Medkova, M., Preininger, A., Mazzoni, M. R., & Hamm, H. E. (2003) · Endocrine Reviews · doi:10.1210/er.2000-0026 · Cited by 661
Signal characteristics of G protein-transactivated EGF receptor
Daub, H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.23.7032 · Cited by 658
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Li, D., Yeung, S. J., Hassan, M. M., Konopleva, M., & Abbruzzese, J. L. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.013 · Cited by 584
Noguchi, K., Ishii, S., & Shimizu, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302648200 · Cited by 557
p53: traffic cop at the crossroads of DNA repair and recombination
Sengupta, S., & Harris, C. C. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1546 · Cited by 544
Katoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
The Wnt signaling pathway and its role in tumor development
Lustig, B., & Behrens, J. (2003) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-003-0431-0 · Cited by 524
Structure–function relationship of estrogen receptor α and β: Impact on human health
Ascenzi, P., Bocedi, A., & Marino, M. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.07.001 · Cited by 499
Wnt signaling: complexity at the surface
Cadigan, K. M., & Liu, Y. I. (2006) · Journal of Cell Science · doi:10.1242/jcs.02826 · Cited by 486
Young, D., Waitches, G., Birchmeier, C., Fasano, O., & Wigler, M. (1986) · Cell · doi:10.1016/0092-8674(86)90785-3 · Cited by 481
GPR92 as a New G12/13- and Gq-coupled Lysophosphatidic Acid Receptor That Increases cAMP, LPA5
Lee, C.-W., Rivera, R., Gardell, S., Dubin, A. E., & Chun, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603670200 · Cited by 471
Van Brocklyn, J. R., Lee, M.-J., Menzeleev, R., Olivera, A., Edsall, L., Cuvillier, O., Thomas, D. M., Coopman, P. J. P., Thangada, S., Liu, C. H., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.229 · Cited by 460
Sodhi, A., Montaner, S., Patel, V., Zohar, M., Bais, C., Mesri, E. A., & Gutkind, J. S. (2000) · PubMed · Cited by 452
Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways
Aoki, J., Taira, A., Takanezawa, Y., Kishi, Y., Hama, K., Kishimoto, T., Mizuno, K., Saku, K., Taguchi, R., & Arai, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206812200 · Cited by 429
Hedgehog beyond medulloblastoma and basal cell carcinoma
Teglund, S., & Toftgård, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.003 · Cited by 426
Thrombin receptor overexpression in malignant and physiological invasion processes
Even-Ram, S., Uziely, B., Cohen, P., Grisaru-Granovsky, S., Maoz, M., Ginzburg, Y., Reich, R., Vlodavsky, I., & Bar-Shavit, R. (1998) · Nature Medicine · doi:10.1038/nm0898-909 · Cited by 417
Yang, T.-Y., Chen, S.-C., Leach, M. W., Manfra, D., Homey, B., Wiekowski, M., Sullivan, L., Jenh, C.-H., Narula, S. K., Chensue, S. W., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.3.445 · Cited by 416
EGFR signal transactivation in cancer cells
Fischer, O. M., Hart, S., Gschwind, A., & Ullrich, A. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311203 · Cited by 411
Ribas, C., Penela, P., Murga, C., Salcedo, A., García-Hoz, C., Jurado-Pueyo, M., Aymerich, I., & Mayor, F. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.019 · Cited by 408
Lysophosphatidic Acid Receptors
Contos, J. J. A., Ishii, I., & Chun, J. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12687-9 · Cited by 404
Albanito, L., Madeo, A., Lappano, R., Vivacqua, A., Rago, V., Carpino, A., Oprea, T. I., Prossnitz, E. R., Musti, A. M., Andò, S., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2909 · Cited by 399
Self-citationNew mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades
Pierce, K. L., Luttrell, L. M., & Lefkowitz, R. J. (2001) · Oncogene · doi:10.1038/sj.onc.1204184 · Cited by 394
Montaner, S., Sodhi, A., Molinolo, A., Bugge, T. H., Sawai, E. T., He, Y., Li, Y., Ray, P. E., & Gutkind, J. S. (2003) · Cancer Cell · doi:10.1016/s1535-6108(02)00237-4 · Cited by 373
GLI transcription factors: Mediators of oncogenic Hedgehog signalling
Kasper, M., Regl, G., Frischauf, A.-M., & Aberger, F. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.039 · Cited by 369
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
Luttrell, L. M., Gesty-Palmer, D., & Sibley, D. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002436 · Cited by 369
CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival
Zhou, Y., Larsen, P. H., Hao, C., & Yong, V. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206222200 · Cited by 363
Filardo, E. J., Graeber, C. T., Quinn, J. A., Resnick, M. B., Giri, D., DeLellis, R. A., Steinhoff, M. M., & Sabo, E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0860 · Cited by 361
The unfolding stories of GPR30, a new membrane-bound estrogen receptor
Maggiolini, M., & Picard, D. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0242 · Cited by 360
Self-citationMechanisms of estrogen signaling and gene expression via GPR30
Prossnitz, E. R., & Maggiolini, M. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.03.026 · Cited by 346
Self-citationSpecific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer
Harkins, L., Volk, A. L., Samanta, M., Mikolaenko, I., Britt, W. J., Bland, K. I., & Cobbs, C. S. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11524-8 · Cited by 346
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342
Vivacqua, A., Bonofiglio, D., Recchia, A. G., Musti, A. M., Picard, D., Andò, S., & Maggiolini, M. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0280 · Cited by 341
Self-citationEstrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF
Pandey, D. P., Lappano, R., Albanito, L., Madeo, A., Maggiolini, M., & Picard, D. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.304 · Cited by 327
Self-citationKisfalvi, K., Eibl, G., Sinnett-Smith, J., & Rozengurt, E. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0418 · Cited by 315
Specific Localisation of Human Cytomegalovirus Nucleic Acids and Proteins in Human Colorectal Cancer
(2003) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2003-41205 · Cited by 292
Feldmann, G., Fendrich, V., McGovern, K., Bedja, D., Bisht, S., Alvarez, H., Koorstra, J.-B. M., Habbe, N., Karikari, C., Mullendore, M., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0573 · Cited by 276
TACE is required for the activation of the EGFR by TGF-α in tumors
Borrell-Pagès, M., Rojo, F., Albanell, J., Baselga, J., & Arribas, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg111 · Cited by 274
Organ selectivity in metastasis: regulation by chemokines and their receptors
Ben-Baruch, A. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9097-3 · Cited by 264
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Tremblay, M. R., Lescarbeau, A., Grogan, M. J., Tan, E., Lin, G., Austad, B. C., Yu, L.-C., Behnke, M. L., Nair, S. J., Hagel, M., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900305z · Cited by 252
Targeting TACE-dependent EGFR ligand shedding in breast cancer
Kenny, P. A., & Bissell, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29518 · Cited by 252
NF‐κB as a potential molecular target for cancer therapy
Lee, C. H., Jeon, Y., Kim, S., & Song, Y. (2007) · BioFactors · doi:10.1002/biof.5520290103 · Cited by 248
Rozengurt, E., Sinnett-Smith, J., & Kisfalvi, K. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2229 · Cited by 247
Nelson, J. B., Love, W., Chin, J. L., Saad, F., Schulman, C. C., Sleep, D. J., Qian, J., Steinberg, J., Carducci, M., & for the Atrasentan Phase 3 Study Group (2008) · Cancer · doi:10.1002/cncr.23864 · Cited by 245
Shan, B.-E., Wang, M.-X., & Li, R.-Q. (2009) · Cancer Investigation · doi:10.1080/07357900802337191 · Cited by 240
Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis
Maussang, D., Verzijl, D., van Walsum, M., Leurs, R., Holl, J., Pleskoff, O., Michel, D., van Dongen, G. A. M. S., & Smit, M. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604433103 · Cited by 233
Overexpression of G protein-coupled receptors in cancer cells: Involvement in tumor progression
Li, S., Huang, S., & Peng, S.-B. (2005) · International Journal of Oncology · doi:10.3892/ijo.27.5.1329 · Cited by 233
The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor
Tabata, K.-I., Baba, K., Shiraishi, A., Ito, M., & Fujita, N. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.09.063 · Cited by 224
GPR30: a novel indicator of poor survival for endometrial carcinoma
Smith, H. O., Leslie, K. K., Singh, M., Qualls, C. R., Revankar, C. M., Joste, N. E., & Prossnitz, E. R. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2007.01.004 · Cited by 214
Chan, Q. K. Y., Lam, H.-M., Ng, C.-F., Lee, A. Y. Y., Chan, E. S. Y., Ng, H.-K., Ho, S.-M., & Lau, K.-M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2010.20 · Cited by 210
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Liu, C.-C., Prior, J., Piwnica-Worms, D., & Bu, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911220107 · Cited by 207
GPR30 predicts poor survival for ovarian cancer
Smith, H. O., Arias-Pulido, H., Kuo, D. Y., Howard, T., Qualls, C. R., Lee, S.-J., Verschraegen, C. F., Hathaway, H. J., Joste, N. E., & Prossnitz, E. R. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.05.015 · Cited by 206
Vazquez-Martin, A., Oliveras-Ferraros, C., Cufí, S., Del Barco, S., Martin-Castillo, B., & Menendez, J. A. (2010) · Cell Cycle · doi:10.4161/cc.9.18.13131 · Cited by 205
Zuo, J., Currin, A., Griffin, B. D., Shannon-Lowe, C., Thomas, W. A., Ressing, M. E., Wiertz, E. J. H. J., & Rowe, M. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000255 · Cited by 204
Hoseong Yang, S., Andl, T., Grachtchouk, V., Wang, A., Liu, J., Syu, L.-J., Ferris, J., Wang, T. S., Glick, A. B., Millar, S. E., et al. (2008) · Nature Genetics · doi:10.1038/ng.192 · Cited by 195
G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival
Radeff‐Huang, J., Seasholtz, T. M., Matteo, R. G., & Brown, J. H. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20094 · Cited by 193
Darmoul, D., Gratio, V., Devaud, H., Lehy, T., & Laburthe, M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64283-6 · Cited by 193
Inhibition of Autotaxin by Lysophosphatidic Acid and Sphingosine 1-Phosphate
van Meeteren, L. A., Ruurs, P., Christodoulou, E., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413183200 · Cited by 191
Veeken, J., Oliveira, S., Schiffelers, R., Storm, G., Henegouwen, P. M. P., & Roovers, R. (2009) · Current Cancer Drug Targets · doi:10.2174/156800909789271495 · Cited by 189
Nam, S. W., Clair, T., Campo, C. K., Lee, H. Y., Liotta, L. A., & Stracke, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203263 · Cited by 187
Yang, M., Zhong, W. W., Srivastava, N., Slavin, A., Yang, J., Hoey, T., & An, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501535102 · Cited by 185
McClanahan, T., Koseoglu, S., Smith, K., Grein, J., Gustafson, E., Black, S., Kirschmeier, P., & Samatar, A. A. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.4.2521 · Cited by 181
Madeo, A., & Maggiolini, M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0408 · Cited by 179
Self-citationMaussang, D., Langemeijer, E., Fitzsimons, C. P., Stigter-van Walsum, M., Dijkman, R., Borg, M. K., Slinger, E., Schreiber, A., Michel, D., Tensen, C. P., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2487 · Cited by 171
Yoo, Y. A., Kang, M. H., Kim, J. S., & Oh, S. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm281 · Cited by 162
Wnt/Fz signaling and the cytoskeleton: potential roles in tumorigenesis
Lai, S.-L., Chien, A. J., & Moon, R. T. (2009) · Cell Research · doi:10.1038/cr.2009.41 · Cited by 161
Regulator of G-protein signaling (RGS) proteins in cancer biology
Hurst, J. H., & Hooks, S. B. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.028 · Cited by 160
Crosstalk between G-protein-coupled receptors and Epidermal growth factor receptor in cancer
Bhola, N. (2008) · Frontiers in Bioscience · doi:10.2741/2805 · Cited by 158
Moskovits, N. B.-C., Kalinkovich, A., Bar, J., Lapidot, T., & Oren, M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2323 · Cited by 155
Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer
Arora, P., Ricks, T. K., & Trejo, J. (2007) · Journal of Cell Science · doi:10.1242/jcs.03409 · Cited by 154
Baker, D. L., Fujiwara, Y., Pigg, K. R., Tsukahara, R., Kobayashi, S. S., Murofushi, H., Uchiyama, A., Murakami‐Murofushi, K., Koh, E., Bandle, R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512486200 · Cited by 153
Thomas, S. M., Bhola, N. E., Zhang, Q. H., Contrucci, S., Wentzel, A. L., Freilino, M. L., Gooding, W. E., Siegfried, J. M., Chan, D. C. F., & Grandis, J. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2876 · Cited by 151
HCMV microinfections in inflammatory diseases and cancer
Söderberg‐Nauclér, C. (2008) · Journal of Clinical Virology · doi:10.1016/j.jcv.2007.11.009 · Cited by 150
Expression cDNA Cloning of a Transforming Gene Encoding the Wild-Type Gα12 Gene Product
Chan, A. M.-L., Fleming, T. P., Mcgovern, E. S., Chedid, M., Miki, T., & Aaronson, S. A. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.2.762 · Cited by 150
The impact of GPCR structures on pharmacology and structure‐based drug design
Congreve, M., & Marshall, F. H. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00476.x · Cited by 149
Wnt signaling in breast cancer: have we come full circle?
Brown, A. M. C. (2001) · Breast Cancer Research · doi:10.1186/bcr321 · Cited by 147
Albanito, L., Sisci, D., Aquila, S., Brunelli, E., Vivacqua, A., Madeo, A., Lappano, R., Pandey, D. P., Picard, D., Mauro, L., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0117 · Cited by 144
Self-citationGα12 and Gα13 Negatively Regulate the Adhesive Functions of Cadherin
Meigs, T. E., Fedor‐Chaiken, M., Kaplan, D. D., Brackenbury, R. W., & Casey, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201984200 · Cited by 137
Bartolomé, R. A., Gálvez, B. G., Longo, N., Baleux, F., van Muijen, G. N. P., Sánchez‐Mateos, P., Arroyo, A. G., & Teixidó, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3398 · Cited by 137
The CXCL12–CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
Epstein, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1473 · Cited by 134
Vivacqua, A., Lappano, R., Marco, P. D., Sisci, D., Aquila, S., Amicis, F. D., Fuqua, S. A. W., Andò, S., & Maggiolini, M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0120 · Cited by 133
Self-citationCinatl, J. J., Vogel, J., Kotchetkov, R., & Doerr, H. W. (2003) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2003.07.005 · Cited by 132
Evaluating Smoothened as a G-protein-coupled receptor for Hedgehog signalling
Ayers, K. L., & Thérond, P. P. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.02.002 · Cited by 130
Bian, D., Mahanivong, C., Yu, J., Frisch, S. M., Pan, Z. K., Ye, R. D., & Huang, S. (2005) · Oncogene · doi:10.1038/sj.onc.1209261 · Cited by 128
Regulation of GPR54 Signaling by GRK2 and β-Arrestin
Pampillo, M., Camuso, N., Taylor, J. E., Szereszewski, J. M., Ahow, M. R., Zajac, M., Millar, R. P., Bhattacharya, M. M., & Babwah, A. V. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0013 · Cited by 126
Young, N. A., & Brocklyn, J. R. V. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.009 · Cited by 126
Ueno, K., Hazama, S., Mitomori, S., Nishioka, M., Suehiro, Y., Hirata, H., Oka, M., Imai, K., Dahiya, R., & Hinoda, Y. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605307 · Cited by 124
Arora, P., Cuevas, B. D., Russo, A., Johnson, G. L., & Trejo, J. (2008) · Oncogene · doi:10.1038/onc.2008.84 · Cited by 124
CARMA3 deficiency abrogates G protein-coupled receptor-induced NF-κB activationPreprint
Grabiner, B. C., Blonska, M., Lin, P.-C., You, Y., Wang, D., Sun, J., Darnay, B. G., Dong, C., & Lin, X. (2007) · Genes & Development · doi:10.1101/gad.1502507 · Cited by 124
Programmed Cellular Necrosis Mediated by the Pore-Forming α-Toxin from Clostridium septicum
Kennedy, C. L., Smith, D. J., Lyras, D., Chakravorty, A., & Rood, J. I. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000516 · Cited by 123
Chung, S., Funakoshi, T., & Civelli, O. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707606 · Cited by 120
Fang, X., Yu, S., LaPushin, R., et al. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520135 · Cited by 119
Thrombin Up-regulates Cathepsin D which Enhances Angiogenesis, Growth, and Metastasis
Hu, L., Roth, J., Brooks, P. C., Luty, J., & Karpatkin, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6276 · Cited by 117
G Proteins in Cancer: The Prostate Cancer Paradigm
Daaka, Y. (2004) · Science s STKE · doi:10.1126/stke.2162004re2 · Cited by 116
Holst, P. J., ROSENKILDE, M. M., Manfra, D. J., Chen, S., Wiekowski, M., Holst, B., Cifire, F., Lipp, M., Schwartz, T. W., & Lira, S. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13622 · Cited by 115
The thrombin receptor, PAR-1, causes transformation by activation of Rho-mediated signaling pathways
Martin, C. B., Mahon, G. M., Klinger, M., Kay, R. J., Symons, M. H., Der, C. J., & Whitehead, I. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204281 · Cited by 115
Beisser, P. S., Verzijl, D., Gruijthuijsen, Y. K., Beuken, E. V. H., Smit, M. J., Leurs, R., Bruggeman, C. A., & Vink, C. (2004) · Journal of Virology · doi:10.1128/jvi.79.1.441-449.2005 · Cited by 114
Baudhuin, L. M., Cristina, K. L., Lü, J., & Xu, Y. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.660 · Cited by 108
Merchant, N. B., Voskresensky, I. V., Rogers, C. M., LaFleur, B., Dempsey, P. J., Graves‐Deal, R., Revetta, F. L., Foutch, A. C., Rothenberg, M. L., Washington, M. K., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1216 · Cited by 107
Hart, S., Fischer, O. M., Prenzel, N., Zwick-Wallasch, E., Schneider, M., Hennighausen, L. G., & Ullrich, A. (2005) · Biological Chemistry · doi:10.1515/bc.2005.099 · Cited by 105
Fishman, P., Bar‐Yehuda, S., Ohana, G., Barer, F., Ochaion, A., Erlanger, A., & Madi, L. (2003) · Oncogene · doi:10.1038/sj.onc.1207355 · Cited by 104
1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity
Miller, K. M., Peukert, S., Jain, R. K., McEwan, M. A., Karki, R., Llamas, L., Yusuff, N., He, F., Li, Y., Sun, Y., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900309j · Cited by 104
Rho GTPases in hepatocellular carcinoma
Grise, F., Bidaud-Meynard, A., & Moreau, V. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.12.003 · Cited by 103
Bcl10 plays a critical role in NF-κB activation induced by G protein-coupled receptors
Wang, D., You, Y., Lin, P.-C., Xue, L., Morris, S. W., Zeng, H., Wen, R., & Lin, X. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601894104 · Cited by 101
Lysophosphatidic acid production and action: Validated targets in cancer?
Umezu‐Goto, M., Tanyi, J. L., Lahad, J. P., Liu, S., Yu, S., LaPushin, R., Hasegawa, Y., Lu, Y., Trost, R., Bevers, T. B., et al. (2004) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20113 · Cited by 99
Jiang, G., Xu, Y., Fujiwara, Y., Tsukahara, T., Tsukahara, R., Gajewiak, J., Tigyi, G., & Prestwich, G. D. (2007) · ChemMedChem · doi:10.1002/cmdc.200600280 · Cited by 98
Chen, M., Towers, L. N., & O’Connor, K. L. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00400.2006 · Cited by 98
Lu, D., Liu, J. X., Endo, T., Zhou, H., Yao, S., Willert, K., Schmidt‐Wolf, I. G. H., Kipps, T. J., & Carson, D. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008294 · Cited by 95
Xu, X., & Prestwich, G. D. (2010) · Cancer · doi:10.1002/cncr.24907 · Cited by 92
Cyclopamine and quercetin suppress the growth of leukemia and lymphoma cells.
Kawahara, T., Kawaguchi-Ihara, N., Okuhashi, Y., Itoh, M., Nara, N., & Tohda, S. (2009) · PubMed · Cited by 92
Rose, R. D., Fernandez, C. S., Smith, M. Z., Batten, C. J., Alcântara, S., Peut, V., Rollman, E., Loh, L., Mason, R. D., Wilson, K. M., et al. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000055 · Cited by 88
Malchinkhuu, E., Sato, K., Horiuchi, Y., Mogi, C., Ohwada, S., Ishiuchi, S., Saito, N., Kurose, H., Tomura, H., & Okajima, F. (2005) · Oncogene · doi:10.1038/sj.onc.1208805 · Cited by 85
Tian (2009) · International Journal of Oncology · doi:10.3892/ijo_00000209 · Cited by 85
G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced Apoptosis
Chen, X., Zhu, H., Yuan, M., Fu, J., Zhou, Y., & Ma, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094243 · Cited by 84
G Protein–Coupled Receptor Connectivity to NF-κB in Inflammation and Cancer
Fraser, C. C. (2008) · International Reviews of Immunology · doi:10.1080/08830180802262765 · Cited by 80
The G Protein Gα13 Is Required for Growth Factor-Induced Cell Migration
Shan, D., Chen, L., Wang, D., Tan, Y.-C., Gu, J. L., & Huang, X. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.03.014 · Cited by 78
Chemokines in tumor-associated angiogenesis
Gerber, P. A., Hippe, A., Buhren, B. A., Müller, A., & Homey, B. (2009) · Biological Chemistry · doi:10.1515/bc.2009.144 · Cited by 74
Frizzled-7 dictates three-dimensional organization of colorectal cancer cell carcinoids
Vincan, E., Darcy, P. K., Farrelly, C. A., Faux, M. C., Brabletz, T., & Ramsay, R. G. (2006) · Oncogene · doi:10.1038/sj.onc.1210026 · Cited by 74
GPR87 Is an Overexpressed G‐Protein Coupled Receptor in Squamous Cell Carcinoma of the Lung
Gugger, M., White, R., Song, S., Waser, B., Cescato, R., Rivière, P. J.-M., & Reubi, J. C. (2007) · Disease Markers · doi:10.1155/2008/857474 · Cited by 73
Fukukawa, C., Nagayama, S., Tsunoda, T., Toguchida, J., Nakamura, Y., & Katagiri, T. (2009) · Oncogene · doi:10.1038/onc.2008.467 · Cited by 73
Kinoshita (2009) · International Journal of Oncology · doi:10.3892/ijo_00000287 · Cited by 73
β-Arrestin 2 is required for lysophosphatidic acid-induced NF-κB activation
Sun, J., & Lin, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802701105 · Cited by 73
Saunders, L. P., Ouellette, A. L., Bandle, R., Chang, W. C., Zhou, H., Misra, R. N., Cruz, E. M. D. L., & Braddock, D. T. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0463 · Cited by 71
Rosanò, L., Castro, V. D., Spinella, F., Tortora, G., Nicotra, M. R., Natali, P. G., & Bagnato, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0883 · Cited by 70
Lai, J.-M., Hsieh, C., & Chang, Z.-F. (2003) · Journal of Cell Science · doi:10.1242/jcs.00660 · Cited by 69
Role of G12 proteins in oncogenesis and metastasis
Juneja, J., & Casey, P. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00180.x · Cited by 68
Voisin, T., Firar, A. E., Rouyer‐Fessard, C., Gratio, V., & Laburthe, M. (2008) · The FASEB Journal · doi:10.1096/fj.07-098723 · Cited by 67
Drugging the Wnt Pathway: Problems And Progress
Garber, K. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp084 · Cited by 64
Rowe, M., & Zuo, J. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.12.001 · Cited by 61
A Current Review of Targeted Therapeutics for Ovarian Cancer
Campos, S. M., & Ghosh, S. (2010) · Journal of Oncology · doi:10.1155/2010/149362 · Cited by 58
Myers, T. J., Brennaman, L. H., Stevenson, M. C., Higashiyama, S., Russell, W. E., Lee, D. C., & Sunnarborg, S. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1256 · Cited by 58
Jeong, K. J., Park, S. Y., Seo, J. H., Lee, K., Choi, W. S., Han, J. W., Kang, J., Park, C. G., Kim, Y. K., & Lee, H. Y. (2008) · Experimental & Molecular Medicine · doi:10.3858/emm.2008.40.6.607 · Cited by 58
Twist Is Required for Thrombin-Induced Tumor Angiogenesis and Growth
Hu, L., Roth, J., Brooks, P. C., Ibrahim, S., & Karpatkin, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0067 · Cited by 58
Mimeault, M., Johansson, S. L., Hénichart, J., Depreux, P., & Batra, S. K. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-1013 · Cited by 58
Murph, M. M., Hurst-Kennedy, J., Newton, V. A., Brindley, D. N., & Radhakrishna, H. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0338 · Cited by 56
Kisfalvi, K., Rey, O., Young, S. H., Sinnett‐Smith, J. W., & Rozengurt, E. (2007) · Endocrinology · doi:10.1210/en.2006-1711 · Cited by 55
Zhang, Y., Qian, Y., Lu, W., & Chen, X. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0621 · Cited by 55
Novel TACE inhibitors in drug discovery: a review of patented compounds
Murumkar, P. R., DasGupta, S., Chandani, S. R., Giridhar, R., & Yadav, M. R. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770903465157 · Cited by 54
Baameur, F., Morgan, D. H., Yao, H., Tran, T. M., Hammitt, R. A., Sabui, S. K., McMurray, J. S., Lichtarge, O., & Clark, R. B. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.058115 · Cited by 49
Revet, I. M., Huizenga, G., Köster, J., Volckmann, R., Sluis, P. V., Versteeg, R., & Geerts, D. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.08.019 · Cited by 47
Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054
Growcott, J. W. (2009) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328320791c · Cited by 46
Importance of p53 for cancer onset and therapy
Haupt, S., & Haupt, Y. (2006) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000217422.52208.fa · Cited by 44
Yang, W., Chang, J., Hsu, S., Li, T., Cho, D., Huang, C., Fong, Y., & Tang, C. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22383 · Cited by 44
Expression of protease-activated receptor 1 in oral squamous cell carcinoma
Liu, Y., Gilcrease, M. Z., Henderson, Y. C., et al. (2001) · Cancer Letters · doi:10.1016/s0304-3835(01)00504-3 · Cited by 42
Remsberg, J. R., Lou, H., Tarasov, S. G., Dean, M. C., & Tarasova, N. I. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705657 · Cited by 39
From purified GPCRs to drug discovery: the promise of protein-based methodologies
Alkhalfioui, F., Magnin, T., & Wagner, R. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.04.002 · Cited by 35
Activated Gα13 Impairs Cell Invasiveness through p190RhoGAP-Mediated Inhibition of RhoA Activity
Bartolomé, R. A., Wright, N., Molina‐Ortiz, I., Sanchez-Luque, F. J., & Teixidó, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0561 · Cited by 34
Modulation of G Protein Signaling Normalizes Tumor Vessels
Manzur, M., Hamzah, J., & Ganß, R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2842 · Cited by 34
Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan
Drake, J. M., Danke, J. R., & Henry, M. D. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.9.8.11112 · Cited by 31
Kenny, P. A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.10.1287 · Cited by 30
Adaptor Protein‐2 Interaction with Arrestin Regulates GPCR Recycling and Apoptosis
Wagener, B. M., Marjon, N. A., Revankar, C. M., & Prossnitz, E. R. (2009) · Traffic · doi:10.1111/j.1600-0854.2009.00957.x · Cited by 30
Pardo, V. G., Martı́n, D., Gutkind, J. S., Verstuyf, A., Bouillon, R., de Boland, A. R., & Boland, R. (2009) · Endocrinology · doi:10.1210/en.2009-0650 · Cited by 29
Wang, P., Chou, F., Bloomston, M., et al. (2008) · Journal of Surgical Research · doi:10.1016/j.jss.2008.05.032 · Cited by 26
Feng, H., Dong, X., Negaard, A., & Feng, P. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000157 · Cited by 26
Chapter 1 GPR56 and Its Related Diseases
Jin, Z., Luo, R., & Piao, X. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)89001-7 · Cited by 22
Fischgräbe, J., Götte, M., Michels, K., Kiesel, L., & Wülfing, P. (2009) · International Journal of Cancer · doi:10.1002/ijc.25076 · Cited by 20
Gastrin-releasing peptide links stressor to cancer progression
Li, X., Lv, Y.-F., Yuan, A., & Li, Z. (2010) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-010-0766-2 · Cited by 15
Siegelin, M. D., Siegelin, Y., Habel, A., Rami, A., & Gaiser, T. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.01.012 · Cited by 9
Cited by
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
Mechanisms of Hippo pathway regulation
Meng, Z., Moroishi, T., & Guan, K.-L. (2016) · Genes & Development · doi:10.1101/gad.274027.115 · Cited by 1,667
The Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Metadata
- Authors
- Lappano, R., & Maggiolini, M.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2010-12-31
- Volume
- 10
- Issue
- 1
- Pages
- 47-60
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2077399441
- Cited by
- 717
- References
- 197
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.